Effects of Moderate/Severe Traumatic Brain Injury in the Subacute or Chronic Phase on Locomotor Strategies Involved in Navigation in Complex Virtual Environments

NCT ID: NCT07230002

Last Updated: 2025-11-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-11-30

Study Completion Date

2026-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

While clinical assessment of locomotor function in this population is carried out using tasks involving walking in a straight line without any obstacles, it does not take into account ecological situations (i.e., situations comparable to real-life situations) in which the person interacts with their environment, such as walking down a street with other pedestrians, which is fundamental to everyday life. This research therefore aims to study the social navigation skills during locomotion of people who have suffered a moderate or severe head injury in the chronic phase in more ecological tasks. This will provide a better understanding of the difficulties encountered by these patients during locomotor interactions in everyday life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Traumatic Brain Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single group

Patients as well as healthy participants will be asked to perform several exercises under virtual reality conditions. Questionnaires and scales will also be completed by the participants.

Group Type EXPERIMENTAL

Locomotion in a virtual reality setting

Intervention Type OTHER

Patients and participants will be asked to perform several walking/locomotion tasks in a virtual evironment setting. The setting in question is a concert in a parc. The participants will have to walk towards the stage whilst avoiding bumping into "virtual people". A total of 5 different tasks (walking in a straight line, walking between people etc) will be completed for each participant. Different variables will then be recorded and extracted such as walking speed, interpersonnal distances, eye fixation times.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Locomotion in a virtual reality setting

Patients and participants will be asked to perform several walking/locomotion tasks in a virtual evironment setting. The setting in question is a concert in a parc. The participants will have to walk towards the stage whilst avoiding bumping into "virtual people". A total of 5 different tasks (walking in a straight line, walking between people etc) will be completed for each participant. Different variables will then be recorded and extracted such as walking speed, interpersonnal distances, eye fixation times.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 ≤ Age ≤ 55 years old
* Male/female
* Having suffered a first non-penetrating head injury
* Moderate to severe severity with initial Glasgow Coma Scale score 5\<GCS\<13
* In the subacute or chronic phase (≥ 3 months at the date of the experiment, relative to the date of the injury)
* Able to walk (10WMT speed ≥ 0.8 m/s, able to walk at least 20 m without technical or human assistance, PM ≥ 300 m)
* Able to maintain dynamic balance while standing (TUG\<16s)
* Able to answer simple questionnaires, according to the investigator's judgment
* Having given their free, informed, expressed (written) consent
* Registered with a social security system
* Individuals under legal protection measures such as guardianship may be eligible


* 18 ≤ Age ≤ 55 years old
* Male/female
* Able to walk (≥ 0.8 m/s, able to walk at least 20 m without technical or human assistance, PM ≥ 300 m)
* Able to answer simple questionnaires, according to the investigator's judgment
* Having given free, informed, expressed (written) consent
* Registered with a social security system

Exclusion Criteria

\- Person under legal protection (excluding guardianship) or unable to express consent


* Severe patho-psychiatric care underway, which may impact the conduct of the protocol, at the investigator's discretion
* Presence of neurological signs suggestive of a neurodegenerative disease responsible for gait disturbance (Parkinson's syndrome, Alzheimer's disease, etc.)
* Individuals with musculoskeletal disorders that impact their locomotor abilities
* Presence of uncontrolled epilepsy at the time of inclusion
* Presence of visual impairments that make experimentation impossible, at the discretion of the investigator
* Pregnant, parturient, or breastfeeding women
* Participants in another ongoing research protocol involving human subjects


* Presence of fatigue, trauma, or a condition affecting mobility, posture, balance, or walking
* Persons deprived of their liberty by a judicial or administrative decision
* Persons deprived of their liberty by judicial or administrative decision
* Persons under legal protection (guardianship, curatorship, judicial protection) or unable to express their consent
* Persons undergoing severe psychiatric treatment or admitted to a health or social care facility for purposes other than research.
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pôle Saint Hélier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fondation Saint Helier

Rennes, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Emilie Leblong, MD

Role: CONTACT

+33299295043

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Emilie Leblong

Role: primary

+33299295043

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2025-A00679-40

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CONTROL Walking Study
NCT03790657 COMPLETED PHASE1